Diagnostic Lab Network

1. Project Overview: Connecting Diagnostic Services

The purpose

Diagnostic testing is an important part of healthcare, but obtaining a test can involve several separate activities: understanding a valid test request, arranging collection, transporting the sample under suitable conditions, processing it, releasing the report and ensuring that the result reaches the appropriate recipient.

Where these activities are poorly coordinated, patients and healthcare providers may face avoidable delays, unclear responsibilities or difficulty tracking the status of a request.

The Diagnostic Lab Network is a proposed way to improve coordination between diagnostic laboratories, healthcare institutions, authorised sample-collection providers and service coordinators. It is intended to work with existing capabilities rather than assume that WARA must establish or operate laboratories itself.

Who may participate

• Diagnostic laboratories that meet applicable requirements for their services.
• Qualified and appropriately authorised sample-collection providers.
• Hospitals, clinics and other healthcare institutions.
• Healthcare professionals who request tests and review results within their professional scope.
• Service coordinators supporting appointment scheduling, communication and non-clinical follow-up.
• Technology or logistics providers engaged for a defined purpose.

Potential project outputs

A project may develop the following, depending on its scope and readiness:

• A register of participating providers and their verified service capabilities.
• Defined workflows for receiving and validating test requests.
• Appointment and sample-collection coordination procedures.
• Sample identification, handling, transport and handover records.
• Laboratory processing and report-release responsibilities.
• Procedures for communicating report availability and managing delays.
• Defined escalation routes for rejected samples, operational incidents and urgent concerns.
• Service-quality and performance-review measures.

No active laboratory network, guaranteed testing volume, route schedule, technology integration or provider agreement is implied.

2. Project Model: From Test Request to Report

The proposed workflow

Valid test request → Booking → Collection → Transport and handover → Laboratory processing → Report release → Appropriate communication

Each stage must have a clearly identified responsible party.

1. Test request: An appropriately authorised healthcare professional or other permitted requester initiates the test request under the applicable rules. The required test, patient identity and relevant instructions must be clear.
2. Booking and preparation: The responsible provider confirms availability, appointment details, preparation requirements and the appropriate collection arrangement.
3. Sample collection: A qualified and authorised person collects the sample where collection is required, following the relevant identification, consent, hygiene and handling procedures.
4. Transport and handover: The responsible parties preserve sample integrity and maintain the required identification, timing, handling and handover records.
5. Laboratory processing: The receiving laboratory checks sample acceptability and performs the requested testing within its authorised scope and quality procedures.
6. Report release: The laboratory validates and releases the report through its approved process. The network must not alter laboratory findings or substitute its own interpretation.
7. Communication and follow-up: Report availability is communicated to the appropriate authorised recipient. Clinical interpretation and decisions remain with the responsible healthcare professional.

Not every test follows an identical workflow. Some require collection at the laboratory, special preparation, time-sensitive transport or other specific conditions. The workflow must reflect the requirements of each test and provider.

Collection points and route-based logistics

A cluster-based collection model could be considered where sufficient demand, suitable geography and qualified staff make it practical. Scheduled routes may help coordinate multiple collection locations, but they should be designed around actual test requirements and transport conditions.

The old proposal suggested coverage zones of 10–15 centres and routine collection routes. These figures should not be treated as established operating assumptions. A viable route depends on local demand, travel time, sample stability, collection hours, laboratory capacity, staffing and cost.

Before a route is activated, the project should establish:

• Participating locations and expected demand.
• Which tests and sample types can be handled through the route.
• Collection and handover schedules.
• Packaging, temperature and transport requirements where applicable.
• Contingency arrangements for delays, rejected samples and transport failure.
• The party accountable for each handover and any resulting incident.

A route should not be optimised for volume or travel efficiency at the expense of sample integrity or patient safety.

Responsibilities of a diagnostic laboratory

A participating laboratory would remain responsible for the testing services it agrees to provide, including the applicable requirements for:

• Authorised scope of testing and personnel.
• Sample acceptance and rejection criteria.
• Laboratory procedures, quality controls and equipment.
• Testing, validation and report release.
• Appropriate retention of records.
• Communication of laboratory-related delays, limitations and incidents.
• Compliance with applicable legal, professional and quality requirements.

Collection providers, transport providers and coordinators must likewise remain accountable for their own agreed responsibilities.

3. Resources and Financial Model

People and infrastructure

Depending on the project, resources may include:

• Laboratory personnel and technical supervision.
• Qualified sample-collection personnel.
• Collection and transport equipment appropriate to the sample types.
• Suitable packaging and handling arrangements.
• Scheduling and service-coordination personnel.
• Secure communication and record-keeping systems.
• Quality, compliance and incident-review support.

A laboratory’s existing capacity must be assessed before additional demand is introduced. Any new collection location, sample-handling arrangement or testing service must meet the requirements applicable to that activity.

Technology and information flow

Technology may support appointment scheduling, request status, collection records, sample handovers, report availability and operational reporting.

A proposed implementation could use existing laboratory systems and agreed interfaces where available. Manual or paper-based procedures may remain necessary where digital integration is unavailable, provided that traceability and security requirements are maintained.

The network must distinguish operational status information from clinical information. A coordinator may need to know whether a sample was collected or a report was released, but should not automatically receive unrestricted access to patient records or laboratory results.

Any system handling patient or health-related information must establish:

• A defined purpose for collecting and sharing each data item.
• Appropriate consent or other lawful authority.
• Role-based access and secure transmission.
• Rules for retention, correction and deletion.
• Audit records and incident-response procedures.
• Clear responsibility for the accuracy and release of information.

No particular WARA software, automated reporting integration or patient-facing dashboard is assumed to exist.

Funding and commercial arrangements

Potential arrangements depend on the specific project and applicable requirements. They may include:

• Direct payment by patients or institutional customers to the relevant provider.
• Contracted diagnostic services for healthcare institutions.
• Agreed fees for collection, transport or coordination services.
• Grants, donations or CSR support for eligible access-oriented programmes.
• Other permitted project-specific funding.

The laboratory’s testing charges, collection fees and any coordination charges should be transparent to the relevant parties. The agreement should define who bills whom, what each party provides, how cancellations and rejected samples are handled, and who is responsible for refunds or service failures.

The network must not assume that participation will produce regular demand, reduce customer-acquisition costs or improve profitability. These are hypotheses to evaluate through an actual pilot.

Wara KarmaYoga Foundation may support eligible charitable health-awareness or community-access activities within its approved objectives and resources. Wara Systems DharmaNet may provide separately contracted technology, workflow or commercial coordination services. These roles should remain distinct.

Wara may receive an agreed payment for actual programme, system, technology, curriculum or implementation services provided to the project, as defined in the project-specific financial arrangement.

4. Governance, Quality and Patient Safety

Diagnostic services require particular care because errors in identification, collection, handling, testing or communication may affect subsequent clinical decisions.

Clinical and professional boundaries

The network’s coordination role must not be confused with laboratory authority or clinical responsibility.

• Tests must be requested and performed under the applicable professional and regulatory requirements.
• Collection and other technical activities must be undertaken by appropriately qualified and authorised personnel.
• Laboratories remain responsible for their testing processes and released reports.
• Clinical interpretation, diagnosis and treatment decisions remain with the appropriate healthcare professional.
• Coordinators must not independently interpret results, advise treatment or change a test request outside their authority.
• Urgent or critical-result communication must follow the laboratory’s and responsible healthcare provider’s approved procedures.

A coordination platform cannot itself guarantee the accuracy of a test, determine a diagnosis or replace a clinician’s judgement.

Sample traceability and quality controls

The project should establish documented procedures for:

• Confirming patient identity and matching it to the request and sample.
• Obtaining required consent and following preparation instructions.
• Labelling samples and recording collection details.
• Maintaining required conditions during storage and transport.
• Recording custody and handovers.
• Identifying unsuitable, damaged, delayed or rejected samples.
• Reporting operational incidents and applying corrective actions.
• Protecting confidential information throughout the process.

Quality requirements should be based on the relevant test, laboratory procedures and applicable standards. A network-level review must not be represented as laboratory accreditation or statutory approval.

Accountability and institutional separation

Principal risks and controls

Institutional Partner and Wara remain independent organisations, each retaining its own governance, personnel, assets and responsibilities. Participation in this project does not by itself create a continuing obligation for Institutional Partner to finance, operate or expand the project, nor does it transfer Wara’s commercial or organisational liabilities to Institutional Partner.

5. Mission Value and Expected Outcomes

Potential value

For patients, better coordination may reduce avoidable confusion about appointments, collection arrangements, sample status and report availability.

For laboratories, clearly defined handovers and communication procedures may help organise participating workflows. Whether these changes improve utilisation, cost or turnaround time must be established from actual operating data.

For healthcare institutions and professionals, a defined process may make it easier to understand where a request stands and whom to contact when a problem occurs.

For communities, suitable partnerships may improve access to diagnostic services where geographic or coordination barriers exist. Any claim about improved access must be supported by evidence from the selected location and population.

Measures of progress

A pilot should select indicators appropriate to the tests and providers involved. Potential measures include:

• Number of providers assessed and formally participating.
• Number of valid test requests received and completed.
• Collection completion and cancellation rates.
• Sample rejection rates and documented reasons.
• Time from collection to laboratory receipt.
• Time from laboratory receipt to report release, measured against the applicable service expectations.
• Number of delayed, lost or misdirected samples and reports.
• Patient or institutional feedback and complaint resolution.
• Actual cost per completed workflow and resource utilisation.

Performance reporting should distinguish operational coordination from clinical outcomes. Faster reporting alone does not establish diagnostic accuracy or improved health outcomes.

A practical path to implementation

The first step should be a feasibility assessment with one suitable laboratory and a clearly defined set of tests or collection arrangements. The assessment should confirm provider authority, actual demand, sample-handling requirements, capacity, workflow ownership, pricing, data protection and escalation procedures.

A pilot should proceed only after the relevant agreements and operating safeguards are in place. Route expansion, additional collection points or system integration should follow only where results demonstrate feasibility and quality can be maintained.

The project is intended to create measurable value within its own scope. If successful, its experience and learning may be reused or adapted for future programmes, subject to separate consideration and approval.